Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 2,403,051
- Share change
- +50,751
- Total reported value
- $16,580,809
- Price per share
- $6.90
- Number of holders
- 19
- Value change
- +$303,012
- Number of buys
- 8
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13F
|
Company |
3%
|
1,351,275
|
$9,896,738 | — | 30 Jun 2023 | |
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,275,000
|
$4,794,000 | — | 27 Jun 2023 | |
| FMR LLC |
13F
|
Company |
1.1%
|
491,746
|
$4,494,558 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
205,154
|
$1,875,108 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
98,300
|
$898,000 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.17%
|
78,831
|
$720,516 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
51,964
|
$474,950 | — | 30 Jun 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
21,463
|
$195,000 | — | 30 Jun 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
20,993
|
$192,000 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
13,719
|
$125,392 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
8,995
|
$82,215 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
4,517
|
$41,285 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,976
|
$18,060 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,254
|
$11,462 | — | 30 Jun 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
1,175
|
$10,739 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
434
|
$3,967 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
218
|
$2,000 | — | 30 Jun 2023 | |
| TFC Financial Management, Inc. |
13F
|
Company |
0%
|
186
|
$1,701 | — | 30 Jun 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$914 | — | 30 Jun 2023 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
12
|
$110 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
605,230
|
— | — | 11 Aug 2022 | |
| Jeryl L. Hilleman |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 27 Sep 2023 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q3 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.